SEP 18, 2018 10:00 AM CEST

WEBINAR: Invitrogen Immunoassays: Vast Choice of Appropriate Tools for Specific Needs

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Senior Manager, Research and Development, Antibodies and Immunoassays, Thermo Fisher Scientific
      Markus leads the R&D group at the Vienna Center of Excellence for Immunoassay Development at Thermo Fisher Scientific. He is responsible for product and technology development as well as contract and custom lab services. Prior to joining Thermo Fisher Scientific, Markus was head of the laboratory for immunoassay development at Affymetrix and was group leader for immunoassay development at eBioscience. Also, he was project leader of R&D for immunoassay development and establishment of new immunoassay technologies (instant ELISA assay; in-house developed, bead-based multiplexing immunoassay technology) at Bender MedSystems GmbH. Markus holds a master's degree from the University of Vienna (Institute of Biochemistry).


    Understanding the complex, yet coordinated protein interactions that sustain life, may help unlock the mysteries of disease mechanisms and thereby treatments. Protein identification and quantification have become extremely valuable in advancing our understanding and finding cures. As there are many methodologies available to scientists today, it can be challenging to choose which tools are the most effective to answer specific questions.

    Based on the decades of market experience in the immunological research reagents market, Thermo Fisher Scientific addresses different customer needs by different technologies for detecting the same analytes and offers a vast choice of appropriate tools for the customer’s specific needs.

    Learning Objectives:

    • Identify time-saving technologies and tools for protein quantitation
    • Understand the benefits of choosing from different immunoassay platforms and formats, all from the same provider

    Show Resources
    Loading Comments...